Facebook Twitter RSS
  • Search this Website
 
Skip to content
  • About Us
    • Our Vision
    • Intervention Strategies
    • Member – Government Committees
    • Annual Reports
    • Our Trustees
    • Donors
    • FCRA Information
  • Our Work
    • Pandemics and COVID-19
      • Helplines
      • Statements
      • High Court Order
      • Articles
      • Community Voices
      • Relief & Other Support for Covid-19
      • Consultations on Gender, Equity & Covid-19 Vaccines
      • Webinar Series Pandemics & Public Health
      • Webinar Series on Vaccine Research & Access
      • Webinars on Covid-19
      • Videos and Podcasts
    • Public Health & Right to Health
    • Surrogacy & ARTs
      • Conference Participation & Seminars
      • Workshops & Discussions
      • Reports & Studies
      • Consultations
      • Film
      • Policy Level Advocacy
      • Publications
      • Media Resources
    • Gender Based Violence
    • Sexual and Reproductive Health
    • Ethics in Clinical Trials, Access to Medicines
    • Young Women and Mental Health
    • Bioethics
    • Early Marriage and Health
    • Population Policies & Two Child Norm
  • Publications
    • Research Reports
    • Consultation Reports
    • Policy Briefs
    • Capacity Building Tools
    • Fact Finding Reports
    • Articles and Edited Volumes
    • Posters
    • Films & Videos
  • Archives
    • Clinical Trials
      • General
      • Affordability
      • Availability & Accessability
      • Compensation
      • Informed Consent
      • Recuritment
      • Bioethics
      • Guidelines & Legislations
  • Photo Gallery
  • Contact
  • Internship
  • Support Us

Category: General

Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk

  By admin Archives, Clinical Trials, General

The National Academies of Sciences, Engineering, Medicine | 14 Jan 2015 Although clinical trials generate vast amounts of data, a large por­tion is never published or made available to other researchers. Data sharing could advance scientific discovery and improve clinical… Continue reading

5 Things to know about India’s Healthcare System

  By admin Archives, Clinical Trials, General

Vijay Ramnath Jayaraman | India Forbes | 2014 Now that the 2014 general elections are in the rear view mirror, Prime Minister Narendra Modi and his ministers face the challenge of expectations set by the media and all his supporters.… Continue reading

Clearing Up Myths and Misconceptions about Clinical Trials

  By admin Archives, Clinical Trials, General

Esther Napolitano | Memorial Sloan Kettering Cancer Centre | 20 October 2014 Medical oncologist Paul Sabbatini demystifies common misconceptions surrounding clinical trials. Read full article Continue reading

Clinical Labor: Tissue Donors and Research Subjects in the Global Bioeconomy

  By admin Archives, Clinical Trials, General

Melinda Cooper, Katherine Waldby | Duke University Press | 2014 Forms of embodied labor, such as surrogacy and participation in clinical trials, are central to biomedical innovation, but they are rarely considered as labor. Melinda Cooper and Catherine Waldby take… Continue reading

Brazilian drug regulator to consider relaxing norms for Indian firms

  By admin Archives, Clinical Trials, General

Sohini Das  |  Business Standard | Ahmedabad | 19 September 2014 Brazil, one of the key export markets in Latin America for Indian pharma companies, is reviewing the proposal to allow Indian laboratories to conduct bioequivalence tests, necessary to grant product… Continue reading

As red tape grows, pharma research flees India

  By admin Archives, Clinical Trials, General

Editorial Comment | Business Standard | New Delhi | 8 September 2014 Piramal Enterprises, the Piramal group’s flagship company operating primarily in the healthcare sector, has decided to close its Mumbai drug research and development (R&D) unit, its largest in… Continue reading

123›»
  • Announcements

    • Innovative practices to address GBV in the Asia Pacific region in the pandemic context 
    • Webinar: “Relooking local production and R&D: Why the TRIPS waiver is still relevant”
    • Short course: GBV & Health systems roles and accountability
    • Webinar on Intersectionality and Equity in Intellectual Property Rights in Healthcare
    • जेन्डर आधारित हिंसा (GBV) के मुद्दे पर कार्यशाला
  • What’s New

    • Dignity in death or discrimination in death?
    • Exploring Intellectual Property and Access to Medicines from a Gender Approach
    • Short course: GBV & Health systems roles and accountability
    • Podcast on the Gender Gap in Covid-19 Vaccinations in India
    • The Unravelling Pandemic: Summary of the Intersectional Feminist Framework
  • Training, Building Capacities and Leadership

    Our Trainings and Capacity Building activities facilitate mobilization and provide support towards organizing around health issues and promoting health rights. They contribute to … Read more »

  • Research

    Research is an integral component of Sama’s work. Research is carried out on issues that the organization is already advocating around or in situations where we feel that there is a need to initiate … Read more »

  • Advocacy

    Sama recognizes the critical role of advocacy in building collective understanding on various issues and to strengthen and sustain campaigns around them. Advocacy initiatives of Sama, including … Read more »

  • Knowledge Creation

    Sama undertakes Creation of Knowledge Resources and their Dissemination on different issues pertaining to women and health. This forms our core strategy on various issues and initiatives that Sama … Read more »

  • About Us
  • Our Work
  • Publications
  • Archives
  • Photo Gallery
  • Contact
  • Internship
  • Support Us
© Sama – Resource Group for Women and Health, 2021
Powered by Parabola & WordPress.
Facebook Twitter RSS